Sienna Biopharmaceuticals Overview
- Year Founded
-
2010
- Status
-
Out of Business
- Employees
-
39
- Latest Deal Type
-
Out of Business
Sienna Biopharmaceuticals General Information
Description
Sienna Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on bringing innovations in biotechnology to the discovery, development, and commercialization of first-in-class, targeted, topical products in medical dermatology and aesthetics. The objective is to develop multi-asset pipeline of topical therapies that enhance the health, appearance, and quality of life of dermatology patients. The product portfolio includes SNA-120, SNA-125, and SNA-001.
Contact Information
Website
www.siennabio.comCorporate Office
- 30699 Russell Ranch Road
- Suite 140
- Westlake Village, CA 91362
- United States
Corporate Office
- 30699 Russell Ranch Road
- Suite 140
- Westlake Village, CA 91362
- United States
Sienna Biopharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Out of Business | 10-Dec-2019 | Completed | Out of Business | |||
| 6. Bankruptcy: Admin/Reorg | 17-Sep-2019 | Completed | Bankruptcy: Admin/Reorg | |||
| 5. IPO | 27-Jul-2017 | Completed | Clinical Trials - Phase 2 | |||
| 4. Later Stage VC (Series B) | 15-May-2017 | Completed | Clinical Trials - General | |||
| 3. Later Stage VC (Series A3) | 18-Jul-2016 | Completed | Clinical Trials - General | |||
| 2. Early Stage VC (Series B) | 20-Jun-2013 | $1.5M | $1.85M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 05-Feb-2013 | $350K | $350K | Completed | Startup |
Sienna Biopharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A3 | ||||||||
| Series A2 | 6,466,287 | $0.000100 | $0.23 | $0.23 | 1x | $0.23 | 6.72% | |
| Series A1 | 2,189,334 | $0.000100 | $0.15 | $0.15 | 1x | $0.15 | 2.28% |
Sienna Biopharmaceuticals Comparisons
Industry
Financing
Details
Sienna Biopharmaceuticals Competitors (2)
One of Sienna Biopharmaceuticals’s 2 competitors is Harrow Health, a Corporation company based in Nashville, TN.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Harrow Health | Corporation | Nashville, TN | ||||
| Exelixis | Formerly VC-backed | Alameda, CA |
Sienna Biopharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Sienna Biopharmaceuticals Patents
Sienna Biopharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20190209472-A1 | Formulations for dermal delivery of polymer conjugates of indolocarbazole compounds with reduced exposure | Inactive | 04-Dec-2017 | ||
| EP-3621657-A1 | Uses of polymer conjugates of indolocarbazole compounds with reduced exposure | Inactive | 10-May-2017 | ||
| EP-3600440-A1 | Reduced exposure conjugates modulating therapeutic targets | Inactive | 20-Mar-2017 | ||
| US-20180071024-A1 | Enhanced efficacy and targeted topical delivery of drugs to skin with nanoparticles | Inactive | 20-Mar-2015 | ||
| US-20160287741-A1 | Metastable silver nanoparticle composites with color indicating properties | Inactive | 18-Nov-2013 | A61K33/38 |
Sienna Biopharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Sienna Biopharmaceuticals Acquisitions (1)
Sienna Biopharmaceuticals’s most recent deal was a Merger/Acquisition with Creabilis for . The deal was made on 06-Dec-2016.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Creabilis | 06-Dec-2016 | Merger/Acquisition | Biotechnology |
Sienna Biopharmaceuticals ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Sienna Biopharmaceuticals FAQs
-
When was Sienna Biopharmaceuticals founded?
Sienna Biopharmaceuticals was founded in 2010.
-
Where is Sienna Biopharmaceuticals headquartered?
Sienna Biopharmaceuticals is headquartered in Westlake Village, CA.
-
What is the size of Sienna Biopharmaceuticals?
Sienna Biopharmaceuticals has 39 total employees.
-
What industry is Sienna Biopharmaceuticals in?
Sienna Biopharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Sienna Biopharmaceuticals a private or public company?
Sienna Biopharmaceuticals is a Private company.
-
What is Sienna Biopharmaceuticals’s current revenue?
The current revenue for Sienna Biopharmaceuticals is .
-
How much funding has Sienna Biopharmaceuticals raised over time?
Sienna Biopharmaceuticals has raised $154M.
-
Who are Sienna Biopharmaceuticals’s competitors?
Harrow Health and Exelixis are competitors of Sienna Biopharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
